查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513619

流感诊断市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 237 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球流感诊断市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 流感诊断市场规模（2024 年）：18 亿美元
  • 预计市值（2033 年）：30 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：6.1%

流感诊断市场 - 报告范围：

流感诊断在流感感染的早期检测、治疗和管理中发挥重要作用。这些诊断包括快速流感诊断测试 (RIDT)、逆转录聚合?链反应 (RT-PCR) 测定和其他分子诊断工具。市场提供各种各样的诊断设备，可以提供及时、准确的结果，以有效管理医院、诊所、诊断实验室和家庭医疗机构的流感流行。

市场成长的驱动力是流感流行的增加、医疗保健支出的增加以及诊断技术进步带来的检测准确性的提高和诊断时间的缩短。

推动市场成长的因素：

全球流感诊断市场由几个关键因素推动，包括提高人们对流感早期诊断和治疗以预防併发症和感染的认识。流感感染发病率的上升以及季节性大流行期间对有效诊断解决方案的需求进一步推动了市场扩张。技术进步，例如高灵敏度和特异性分子诊断工具的开发，正在提高检测率并缩短週转时间，从而推动市场成长。此外，扩大采用现场检测和家庭诊断解决方案，为市场进入者接触更多患者群体开闢了新途径。

市场限制因素：

儘管成长前景广阔，流感诊断市场仍面临监管合规、报销政策和替代诊断竞争等方面的挑战。有关诊断设备的製造、销售和使用的严格法规给製造商和医疗保健提供者带来了合规负担，影响了市场进入障碍和营运成本。此外，诊断测试的报销范围有限以及先进诊断设备的高成本对市场渗透构成了挑战，特别是在医疗保健预算有限的新兴国家。解决这些监管和经济障碍需要行业利益相关者和政策制定者之间的合作，以促进获得准确且负担得起的诊断解决方案。

市场机会：

由于技术创新、人口趋势和不断发展的医疗保健服务模式，流感诊断市场呈现出巨大的成长机会。远端监控和远距医疗平台等数位医疗技术的集成，增加了患者获得诊断服务的机会，并提高了治疗依从性和结果。此外，扩大流感以外的诊断应用，例如检测其他呼吸道病毒和传染病，将扩大市场范围并促进创新。策略合作伙伴关係、研发投资以及推出用户友好且具有成本效益的诊断解决方案对于利用新的商机并保持在动态诊断市场的领先地位至关重要。

本报告解决的关键问题

  • 推动全球流感诊断市场成长的关键因素是什么？
  • 哪些诊断类型和应用正在推动各种医疗机构中的流感诊断？
  • 科技进步如何改变流感诊断市场的竞争格局？
  • 谁是流感诊断市场的主要参与者？
  • 全球流感诊断市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 蕴藏事项·除外事项

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 主要成功因素

  • 产品的采用/使用情形分析
  • 产品的USP/特征
  • 策略和推销策略
  • 主要的法规
  • 疾病流行病学
  • 大环境分析
  • 波特分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素 - 相关性及影响
  • 动态

第6章 COVID-19危机分析

  • COVID-19及影响分析
    • 检查别
    • 各流感类型
    • 各终端用户
  • 2024年的市场情势

第7章 全球流感诊断市场需求(金额或规模，10亿美元)分析

  • 过去的市场金额(10亿美元)的分析，2019年～2023年
  • 现在及未来市场金额(10亿美元)预测，2024年～2033年
    • 前一年同期比较成长趋势分析
    • 绝对额的机会分析

第8章 全球流感诊断市场分析:检查别

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)的分析:检查别，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:检查别，2024年～2033年
    • 分子诊断检验
    • 传统的诊断试验
  • 市场魅力分析:检查别

第9章 全球流感诊断市场分析:各流感类型

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)的分析:各流感类型，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各流感类型，2024年～2033年
    • A型流感
    • B型流感
    • C型流感
  • 市场魅力分析:各流感类型

第10章 全球流感诊断市场分析:各终端用户

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)的分析:各终端用户，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各终端用户，2024年～2033年
    • 医院
    • 诊断检验室
    • 研究·学术机构
    • 契约调查机关(CRO)
  • 市场魅力分析:各终端用户

第11章 全球流感诊断市场分析:各地区

  • 简介
  • 过去的市场规模(10亿美元)的分析:各地区，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东·非洲(MEA)
  • 市场魅力分析:各地区

第12章 北美的流感诊断市场分析

第13章 南美的流感诊断市场分析

第14章 欧洲的流感诊断市场分析

第15章 南亚的流感诊断市场分析

第16章 东亚的流感诊断市场分析

第17章 大洋洲的流感诊断市场分析

第18章 中东·非洲的流感诊断市场分析

第19章 市场结构分析

  • 市场分析:企业各层级
  • 主要企业的市场占有率分析
  • 市场集中
  • 市场影响分析

第20章 竞争分析

  • 竞争仪表板
  • 竞争的详细资讯
    • Abbott Laboratories
    • Endress+Hauser(Analytik Jena AG)
    • Becton, Dickinson and Company
    • Biocartis
    • bioMerieux Inc
    • Danaher Corporation(Cepheid)
    • F. Hoffmann-La Roche Ltd
    • GenMark Diagnostics, Inc.
    • Luminex Corporation
    • Meridian Bioscience, Inc
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Hologic

第21章 所使用的前提条件与缩写

第22章 调查手法

简介目录
Product Code: PMRREP13246

Persistence Market Research has recently released a comprehensive report on the worldwide market for influenza diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Influenza Diagnostics Market Size (2024E): USD 1.8 Billion
  • Projected Market Value (2033F): USD 3.0 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.1%

Influenza Diagnostics Market - Report Scope:

Influenza diagnostics play a crucial role in the early detection, treatment, and management of influenza infections. These diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR) assays, and other molecular diagnostic tools. The market serves hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of diagnostic devices that provide timely and accurate results to manage influenza outbreaks effectively.

Market growth is driven by increasing prevalence of influenza, rising healthcare expenditures, and advancements in diagnostic technology, enhancing detection accuracy and reducing diagnostic time.

Market Growth Drivers:

The global influenza diagnostics market is propelled by several key factors, including growing awareness about early diagnosis and treatment of influenza to prevent complications and transmission. The rising incidence of influenza infections, coupled with the demand for effective diagnostic solutions during seasonal outbreaks, further drives market expansion. Technological advancements, such as the development of highly sensitive and specific molecular diagnostic tools, offer improved detection rates and shorter turnaround times, fostering market growth. Moreover, the increasing adoption of point-of-care testing and home-based diagnostic solutions creates new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the influenza diagnostics market faces challenges related to regulatory compliance, reimbursement policies, and competition from alternative diagnostic methods. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for diagnostic tests and the high cost of advanced diagnostic equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to accurate and affordable diagnostic solutions.

Market Opportunities:

The influenza diagnostics market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of diagnostics beyond influenza, including in the detection of other respiratory viruses and infections, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic diagnostics landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the influenza diagnostics market globally?
  • Which diagnostic types and applications are driving influenza diagnosis across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the influenza diagnostics market?
  • Who are the key players contributing to the influenza diagnostics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global influenza diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the global influenza diagnostics market, including Roche Diagnostics, Abbott Laboratories, and Quidel Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular assays and point-of-care tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving diagnostics landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • Endress+Hauser (Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Inc
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Hologic

Key Segments Covered in Influenza Diagnostics Industry Research

Test:

  • Molecular Diagnostic Test
  • Traditional Diagnostic Test

Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research & Academic Institute
  • Contract Research Organization (CRO's)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic and Promotional Strategies
  • 4.4. Key Regulations
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Market Outlook
    • 5.1.3. Global Infectious Disease Diagnostics Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
    • 5.2.2. Application Innovation in Influenza Diagnostics
    • 5.2.3. Product Adoption Rate
    • 5.2.4. Regulatory Impositions
    • 5.2.5. Growing R&D Investments
    • 5.2.6. Novel Diagnostic Product Development Activities
    • 5.2.7. Awareness Campaigns for Influenza Diagnostics
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Test
    • 6.1.2. By Type of Flu
    • 6.1.3. By End User
  • 6.2. 2024 Market Scenario

7. Global Influenza Diagnostics Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Test

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Test, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Test, 2024-2033
    • 8.3.1. Molecular Diagnostics Tests
      • 8.3.1.1. RT-PCR
      • 8.3.1.2. LAMP
      • 8.3.1.3. NASABA
    • 8.3.2. Traditional Diagnostics Tests
      • 8.3.2.1. Rapid Influenza Detection Kits
      • 8.3.2.2. Serological Assays
      • 8.3.2.3. Direct Fluorescent Antibody
      • 8.3.2.4. Viral Culture
      • 8.3.2.5. H1N1 Influenza A Virus Identification Kits
      • 8.3.2.6. Immunoassay Kits
      • 8.3.2.7. Immunofluorescence Antibody Assay
  • 8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Flu

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Type of Flu, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type of Flu, 2024-2033
    • 9.3.1. Type A Flu
    • 9.3.2. Type B Flu
    • 9.3.3. Type C Flu
  • 9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Research & Academic Institutes
    • 10.3.4. Contract Research Organizations (CRO)
  • 10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Test
    • 12.3.3. By Type of Flu
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Test
    • 12.4.3. By Type of Flu
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Influenza Diagnostics Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Test
        • 12.5.1.2.2. By Type of Flu
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Influenza Diagnostics Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Test
        • 12.5.2.2.2. By Type of Flu
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis
  • 12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Test
    • 13.3.3. By Type of Flu
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Test
    • 13.4.3. By Type of Flu
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Influenza Diagnostics Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Test
        • 13.5.1.2.2. By Type of Flu
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Influenza Diagnostics Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Test
        • 13.5.2.2.2. By Type of Flu
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Influenza Diagnostics Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Test
        • 13.5.3.2.2. By Type of Flu
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis
  • 13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Test
    • 14.3.3. By Type of Flu
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Test
    • 14.4.3. By Type of Flu
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Influenza Diagnostics Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Test
        • 14.5.1.2.2. By Type of Flu
        • 14.5.1.2.3. By End User
    • 14.5.2. France Influenza Diagnostics Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Test
        • 14.5.2.2.2. By Type of Flu
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Influenza Diagnostics Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Test
        • 14.5.3.2.2. By Type of Flu
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Influenza Diagnostics Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Test
        • 14.5.4.2.2. By Type of Flu
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Influenza Diagnostics Market Analysis
      • 14.5.5.1. Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Test
        • 14.5.5.2.2. By Type of Flu
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Influenza Diagnostics Market Analysis
      • 14.5.6.1. Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Test
        • 14.5.6.2.2. By Type of Flu
        • 14.5.6.2.3. By End User
    • 14.5.7. BENELUX Influenza Diagnostics Market Analysis
      • 14.5.7.1. Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Test
        • 14.5.7.2.2. By Type of Flu
        • 14.5.7.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis
  • 14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Test
    • 15.3.3. By Type of Flu
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Test
    • 15.4.3. By Type of Flu
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Influenza Diagnostics Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Test
        • 15.5.1.2.2. By Type of Flu
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Influenza Diagnostics Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Test
        • 15.5.2.2.2. By Type of Flu
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Influenza Diagnostics Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Test
        • 15.5.3.2.2. By Type of Flu
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Influenza Diagnostics Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Test
        • 15.5.4.2.2. By Type of Flu
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Test
    • 16.3.3. By Type of Flu
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Test
    • 16.4.3. By Type of Flu
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Influenza Diagnostics Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Test
        • 16.5.1.2.2. By Type of Flu
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Influenza Diagnostics Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Test
        • 16.5.2.2.2. By Type of Flu
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Influenza Diagnostics Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Test
        • 16.5.3.2.2. By Type of Flu
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Test
    • 17.3.3. By Type of Flu
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Test
    • 17.4.3. By Type of Flu
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Influenza Diagnostics Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Test
        • 17.5.1.2.2. By Type of Flu
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Influenza Diagnostics Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Test
        • 17.5.2.2.2. By Type of Flu
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Test
    • 18.3.3. By Type of Flu
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Test
    • 18.4.3. By Type of Flu
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Test
        • 18.5.1.2.2. By Type of Flu
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkey Influenza Diagnostics Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Test
        • 18.5.2.2.2. By Type of Flu
        • 18.5.2.2.3. By End User
    • 18.5.3. South Africa Influenza Diagnostics Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Test
        • 18.5.3.2.2. By Type of Flu
        • 18.5.3.2.3. By End User
    • 18.5.4. North Africa Influenza Diagnostics Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Test
        • 18.5.4.2.2. By Type of Flu
        • 18.5.4.2.3. By End User
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Key Market Participants - Intensity Mapping
  • 18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Abbott Laboratories
      • 20.2.1.1. Overview
      • 20.2.1.2. Product Portfolio
      • 20.2.1.3. Key Financials
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. Strategy Overview
        • 20.2.1.5.1. Marketing Strategy
        • 20.2.1.5.2. Product Strategy
        • 20.2.1.5.3. Channel Strategy
    • 20.2.2. Endress+Hauser (Analytik Jena AG)
      • 20.2.2.1. Overview
      • 20.2.2.2. Product Portfolio
      • 20.2.2.3. Key Financials
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. Strategy Overview
        • 20.2.2.5.1. Marketing Strategy
        • 20.2.2.5.2. Product Strategy
        • 20.2.2.5.3. Channel Strategy
    • 20.2.3. Becton, Dickinson and Company
      • 20.2.3.1. Overview
      • 20.2.3.2. Product Portfolio
      • 20.2.3.3. Key Financials
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. Strategy Overview
        • 20.2.3.5.1. Marketing Strategy
        • 20.2.3.5.2. Product Strategy
        • 20.2.3.5.3. Channel Strategy
    • 20.2.4. Biocartis
      • 20.2.4.1. Overview
      • 20.2.4.2. Product Portfolio
      • 20.2.4.3. Key Financials
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. Strategy Overview
        • 20.2.4.5.1. Marketing Strategy
        • 20.2.4.5.2. Product Strategy
        • 20.2.4.5.3. Channel Strategy
    • 20.2.5. bioMerieux Inc
      • 20.2.5.1. Overview
      • 20.2.5.2. Product Portfolio
      • 20.2.5.3. Key Financials
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. Strategy Overview
        • 20.2.5.5.1. Marketing Strategy
        • 20.2.5.5.2. Product Strategy
        • 20.2.5.5.3. Channel Strategy
    • 20.2.6. Danaher Corporation (Cepheid)
      • 20.2.6.1. Overview
      • 20.2.6.2. Product Portfolio
      • 20.2.6.3. Key Financials
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. Strategy Overview
        • 20.2.6.5.1. Marketing Strategy
        • 20.2.6.5.2. Product Strategy
        • 20.2.6.5.3. Channel Strategy
    • 20.2.7. F. Hoffmann-La Roche Ltd
      • 20.2.7.1. Overview
      • 20.2.7.2. Product Portfolio
      • 20.2.7.3. Key Financials
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. Strategy Overview
        • 20.2.7.5.1. Marketing Strategy
        • 20.2.7.5.2. Product Strategy
        • 20.2.7.5.3. Channel Strategy
    • 20.2.8. GenMark Diagnostics, Inc.
      • 20.2.8.1. Overview
      • 20.2.8.2. Product Portfolio
      • 20.2.8.3. Key Financials
      • 20.2.8.4. Sales Footprint
      • 20.2.8.5. Strategy Overview
        • 20.2.8.5.1. Marketing Strategy
        • 20.2.8.5.2. Product Strategy
        • 20.2.8.5.3. Channel Strategy
    • 20.2.9. Luminex Corporation
      • 20.2.9.1. Overview
      • 20.2.9.2. Product Portfolio
      • 20.2.9.3. Key Financials
      • 20.2.9.4. Sales Footprint
      • 20.2.9.5. Strategy Overview
        • 20.2.9.5.1. Marketing Strategy
        • 20.2.9.5.2. Product Strategy
        • 20.2.9.5.3. Channel Strategy
    • 20.2.10. Meridian Bioscience, Inc
      • 20.2.10.1. Overview
      • 20.2.10.2. Product Portfolio
      • 20.2.10.3. Key Financials
      • 20.2.10.4. Sales Footprint
      • 20.2.10.5. Strategy Overview
        • 20.2.10.5.1. Marketing Strategy
        • 20.2.10.5.2. Product Strategy
        • 20.2.10.5.3. Channel Strategy
    • 20.2.11. Quidel Corporation
      • 20.2.11.1. Overview
      • 20.2.11.2. Product Portfolio
      • 20.2.11.3. Key Financials
      • 20.2.11.4. Sales Footprint
      • 20.2.11.5. Strategy Overview
        • 20.2.11.5.1. Marketing Strategy
        • 20.2.11.5.2. Product Strategy
        • 20.2.11.5.3. Channel Strategy
    • 20.2.12. Thermo Fisher Scientific Inc.
      • 20.2.12.1. Overview
      • 20.2.12.2. Product Portfolio
      • 20.2.12.3. Key Financials
      • 20.2.12.4. Sales Footprint
      • 20.2.12.5. Strategy Overview
        • 20.2.12.5.1. Marketing Strategy
        • 20.2.12.5.2. Product Strategy
        • 20.2.12.5.3. Channel Strategy
    • 20.2.13. Hologic
      • 20.2.13.1. Overview
      • 20.2.13.2. Product Portfolio
      • 20.2.13.3. Key Financials
      • 20.2.13.4. Sales Footprint
      • 20.2.13.5. Strategy Overview
        • 20.2.13.5.1. Marketing Strategy
        • 20.2.13.5.2. Product Strategy
        • 20.2.13.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology